Synchrotron-related events in Australia and overseas.

A new round of funding is available for Victorian companies to turn their innovative ideas into commercial products under the joint fund agreement between the State of Victoria and Israel.

The Australian Synchrotron has appointed two new members to the Board of Directors: Professor Max Lu from the University of Queensland and Professor Keith Nugent from the University of Melbourne.

Secrets of the Mona Lisa
Butterfly Wings
Amber Lights up at ESRF
Water-splitting Photocatalyst
Platinum Standard
National Science Colloquium

SAXS on the ABC
Arsenic and toenails
Arsenic and Phar Lap
New discovery could stop cancer in its track
Australopithecus may have brains
Honour for John Boldeman
Synchrotron Kiwis feature on Maori TV

Drugs work best when our digestive system can absorb them completely so they can pass into the bloodstream and become available where they are of most use. Because most drugs can only partly dissolve in the watery environments inside our bodies, new drug products increasingly use oil-based ‘soft-gel’ formulations. Studies of how oily (lipid-based) drug products behave in our digestive system are helping to guide the development of more effective drug products.

Selenium supplements may help prevent a wide range of cancers such as colon cancer, but too much selenium can lead to cardiovascular problems and other health issues. The gap between selenium benefits and selenium toxicity is surprisingly small, and is strongly influenced by the chemical form of selenium that is ingested.

Beamtime submissions open on 7 September 2010 for round 2011/1 (January-May 2011).

Beamtime submissions open on 1 June 2010 for round 2010/3 (September-December 2010).

The Australian Synchrotron Open Day on Sunday 15 August 2010 is your chance to encounter one of Australia’s most exciting scientific facilities and see how synchrotron science can make life better for everyone. Come and see us for yourself… or volunteer to help behind the scenes!